Gain Therapeutics GANX
NASDAQ GANX
$1.19 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Payables (2020 - 2026)

Updated

Gain Therapeutics (GANX) recorded Payables of $1.22 million in Q2 2026, down 55.0% from $2.71 million a year earlier and down 19.5% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Payables (2020 - 2026) Analysis & Trends

At the end of FY2025, Gain Therapeutics reported Payables of $825,027, down 12.8% from FY2024.

  • Annual Payables has declined for three straight years, with a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
  • Across earlier years, Payables came in at $946,259 in FY2024 (-28.3%), $1.32 million in FY2023 (-18.9%), $1.63 million in FY2022 (+190.1%) and $560,479 in FY2021 (-41.7%).
  • Quarterly Payables has ranged from $560,479 in Q4 2021 to $2.71 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Payables has declined for three consecutive quarters, with an average decline of 1.8% over the last eight quarters.
  • Peak year-over-year performance for Payables in the last five years was growth of 190.1% in Q4 2022, against a decline of 55.0% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.52 million (Q1 2026), $825,027 (Q4 2025) and $1.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.92 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.30 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 7.03 Bn
10 Gain Therapeutics 51.03 Mn -8.26 Mn - 1.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.22 Mn
Mar 31, 2026 1.52 Mn
Dec 31, 2025 825,027.00
Sep 30, 2025 1.60 Mn
Jun 30, 2025 2.71 Mn
Mar 31, 2025 2.20 Mn
Dec 31, 2024 946,259.00
Sep 30, 2024 1.10 Mn
Jun 30, 2024 2.05 Mn
Mar 31, 2024 1.41 Mn
Dec 31, 2023 1.32 Mn
Sep 30, 2023 1.40 Mn
Jun 30, 2023 924,390.00
Mar 31, 2023 2.21 Mn
Dec 31, 2022 1.63 Mn
Sep 30, 2022 1.02 Mn
Jun 30, 2022 948,902.00
Mar 31, 2022 2.12 Mn
Dec 31, 2021 560,479.00
Sep 30, 2021 789,387.00
API Access

Gain Therapeutics Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=GANX&period=max&api_key=YOUR_API_KEY